Nektar Therapeutics

Nektar Therapeutics (NKTR) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GNKTRFiled Nov 10, 2026, 3:44 AM ET

About this filing

Nektar Therapeutics (NKTR) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 10, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More NKTR filings

S-8
SEC filing
Filed Oct 19, 2026
8-K
Current report
Filed Oct 1, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Sep 28, 2026
4
Insider transaction
Filed Sep 25, 2026
4
Insider transaction
Filed Sep 25, 2026
4
Insider transaction
Filed Sep 25, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.